SDF-1 在哮喘大鼠肺组织中的表达及 AMD3100 的干预作用

邹丽萍; 王利霞; 张艳; 杜文丽

PDF(1367 KB)

中国当代儿科杂志 ›› 2011, Vol. 13 ›› Issue (4) : 321-325.

论著·实验研究

SDF-1 在哮喘大鼠肺组织中的表达及 AMD3100 的干预作用

邹丽萍，王利霞，张艳，杜文丽

作者信息 +

Expression of SDF-1 in lung tissues and intervention of AMD3100 in asthmatic rats

ZOU Li-Ping, WANG Li-Xia, ZHANG Yan, DU Wen-Li

Author information +

文章历史 +

摘要

目的：探讨基质细胞衍生因子-1（SDF-1）在哮喘大鼠肺组织中的表达及其拮抗剂AMD3100的干预作用。方法：30 只雌性 Sprague-Dawley 大鼠随机分为对照组、哮喘组、干预组，以卵白蛋白激发制备哮喘模型；干预组于激发前 30 min给予 AMD3100 (50 μg, 隔日 1 次，共 10 次)。光镜下观察各组气道炎症及气道壁结构的情况；酶联免疫吸附法测定肺组织匀浆中 IL-4、IL-5 的水平；RT-PCR 检测 SDF-1 mRNA 在肺组织中的表达。结果哮喘组气道壁厚度较对照组及干预组显著增厚（P<0.05）；干预组IL-4、IL-5 的水平明显低于哮喘组（P<0.05）；哮喘组中SDF-1 mRNA 明显高于对照组及干预组(P<0.05)。结论：SDF-1可能参与哮喘大鼠气道炎症反应和气道重塑过程；AMD3100 能够改善哮喘大鼠的气道炎症和气道重塑，可能与拮抗 SDF-1 的生物活性有关。

Abstract

OBJECTIVE: To study the expression of stromal cell derived factor-1(SDF-1) in the airway and to investigate the role of SDF-1 receptor antagonist AMD3100 intervention in rats with asthma. METHODS: Thirty Sprague-Dawley rats were randomly divided into three groups: normal control and asthma with and without AMD3100 intervention. The rat model of asthma was prepared by aerosolized ovalbum (OVA) challenge. The AMD3100 intervention group was administered with AMD3100 of 50 μg 30 minutes before challenge every other day, for 10 times. The characteristic airway inflammation and alterations of airway structures were observed by hemetoxylin and eosin staining. The levels of interleukin 4 and interleukin 5 in whole lung homogenates were measured using ELISA. RT-PCR was used to evaluate the expression of SDF-1 mRNA in the lung. RESULTS: The airway wall thickness in the untreated asthma group was greater than that in the control and the AMD3100 intervention groups (P<0.05). The levels of interleukin 4 and interleukin 5 in whole lung homogenates in the AMD3100 intervention group were lower than those in the untreated asthma group (P<0.05). The expression of SDF-1 mRNA in the untreated asthma group was higher than that in the control and the AMD3100 intervention groups (P<0.05). CONCLUSIONS: SDF-1 may be associated with airway inflammation and remodeling in rats with asthma. AMD3100 may reduce the airway inflammation and improve airway remodeling by inhibiting the bioactivity of SDF-1.

导出引用

邹丽萍，王利霞，张艳，杜文丽. SDF-1 在哮喘大鼠肺组织中的表达及 AMD3100 的干预作用[J]. 中国当代儿科杂志. 2011, 13(4): 321-325

ZOU Li-Ping, WANG Li-Xia, ZHANG Yan, DU Wen-Li. Expression of SDF-1 in lung tissues and intervention of AMD3100 in asthmatic rats[J]. Chinese Journal of Contemporary Pediatrics. 2011, 13(4): 321-325

中图分类号： R-33

参考文献

［1］Altenburg JD, Broxmeyer HE, Jin Q, Cooper S, Basu S, Alkhatib G. A naturally occurring splice variant of CXCL12/stromal cell-derived factor 1 is a potent human immunodeficiency virus type 1 inhibitor with weak chemotaxis and cell survival activities［J］. J Virol, 2007, 81(15): 8140-8148.

［2］Negrete-Garcia MC, Velazquez JR, Popoca-Coyotl A, Montes-Vizuet AR, Juárez-Carvajal E, Teran LM. Chemokine (C-X-C motif) ligand 12/stromal cell-derived factor-1 is associated with leukocyte recruitment in asthma［J］. Chest, 2010, 138(1): 100-106.

［3］栾斌，黄先杰，乔俊英. SDF-1及CXCR4在哮喘小鼠肺组织中的表达及布地奈德的干预作用［J］. 中国当代儿科杂志，2010，12（3）：215-218.

［4］张艳，邹丽萍，栾斌，韩素鸽. 糖皮质激素对哮喘大鼠肺神经生长因子表达的影响［J］.实用儿科临床杂志，2007，22(9) ：685-686.

［5］彭亮红. CXCR4 特异性拮抗剂 AMD3100 对小鼠角膜碱烧伤新生血管的治疗作用及其机制的研究［D］. 第二军医大学，2009.

［6］徐庆玥. 氧诱导视网膜病变小鼠模型中 SDF-1 及 VEGF 的表达及 AMD3100 对其的干预［D］. 复旦大学，2009.

［7］Hoshino M, Aoike N, Takahashi M, Nakamura Y, Nakagawa T. Increased immunoreactivity of stromal cell-derived factor-1 and angiogenesis in asthma［J］. Eur Respir J, 2003, 21(5):804-809.

［8］Coyle AJ, Wagner K, Bertrand C, Tsuyki S, Bews J, Heusser C. Central role of immunoglobulin (lg)E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylatogenic anti-IgE antibody［J］. J Exp Med, 1996, 183(4): 1303-1310.

［9］Gonzalo JA, Lloyd CM, Peled A, Delaney T, Coyle AJ, Gutierrez-Ramos JC. Critical involvement of the chemotactic axis CXCR4/stromal cell-derived factor-1alpha in the inflammatory component of allergic airway disease［J］. J Immunol, 2000, 165(1): 499-508.

［10］Ding Z, Issekutz TB, Downey GP, Waddell TK. L-selectin stimulation enhances functional expression of surface CXCR4 in lymphocytes: implications for cellular activation during adhesion and migration［J］. Blood, 2003, 101(11): 4245-4252.

［11］Zhang S, Qi L, Li M, Zhang D, Xu S ,Wang N, et al. Chemokine CXCL12 and its receptor CXCR4 expression are associated with perineural invasion of prostate cancer［J］. J Exp Clin Cancer Res, 2008, 27: 62.

［12］Carr AN, Howard BW, Yang HT, EbyWilkens E, Loos P, Varbanov A, et al. Efficacy of systemic administration of SDF-1 in a model of vascular insufficiency: support for an endotheliumdependent mechanism［J］. Cardiovasc Res, 2006, 69(4): 925-935.

［13］Su X, Taniuchi N, Jin E, Fujiwara M, Zhang L, Ghazizadeh M, et al. Spatial and phenotypic characterization of vascular remodeling in a mouse model of asthma［J］. Pathobiology, 2008, 75(1): 42-56.

［14］McDonald DM. Angiogenesis and remodeling of airway vasculature in chronic inflammation［J］. Am Respir Crit Care Med, 2001, 164(10 Pt 2): S39-S45.

［15］Lukacs NW, Berlin A, Schols D, Skerlj RT, Bridger GJ. AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity［J］. Am Pathol, 2002, 160(4): 1353-1360.